Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0376 USD | -5.16% | -5.28% | +6.50% |
Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 43
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Herb-based Supplements and Hemp-based Cannabidiol
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,228,469 | 163,197,469 ( 99.98 %) | 0 | 99.98 % |
Stock B | 0 | 1,000 | 0 | 0 |
Company contact information
CV Sciences, Inc.
9530 Padgett Street Suite 107
92126, San Diego
+866 290 2157
http://www.cvsciences.comSector
1st Jan change | Capi. | |
---|---|---|
+6.50% | 6.15M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CVSI Stock
- Company CV Sciences, Inc.